Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-06-02 | Robert “Bob” Moccia assumed the duties of Chief Executive Officer and member of the Board on March 1, 2021. ... Employment Agreement with Robert Moccia ... Mr. Moccia’s employment agreement provides him with severance benefits in the event that his employment is terminated under certain circumstances, including by Mr. Moccia for “Good Reason” and by the Company without “Cause” (each as defined in his employment agreement). Upon the termination of Mr. Moccia’s employment, he will automatically resign as a member of the Company’s board of directors. |
| 2022-05-18 | Robert “Bob” Moccia assumed the duties of Chief Executive Officer and member of the Board on March 1, 2021. Mr. Moccia has more than 20 years of executive management experience as President, COO, and CEO of small to mid-sized specialty pharmaceutical companies and over 35 years of global pharmaceutical experience with expertise in general management, operations, strategic planning, business development, product development, sales, marketing, and building customer focused organizations. ... The following table includes information for the years ended December 31, 2021, and 2020 concerning compensation for our named executive officers. ... Robert Moccia Director, President and Chief Executive Officer as of 3/1/21 2021 Salary 416,346 Non-Equity Incentive Plan Compensation 299,677 Options 2,102,776 All Other Compensation 18,804 Total 3,559,208. |
| 2023-09-25 | Robert “Bob” Moccia assumed the duties of Chief Executive Officer and member of the Board on March 1, 2021. Mr. Moccia has more than 20 years of executive management experience as President, COO, and CEO of small to mid-sized specialty pharmaceutical companies and over 35 years of global pharmaceutical experience with expertise in general management, operations, strategic planning, business development, product development, sales, marketing, and building customer focused organizations. ... Mr. Moccia's qualifications to serve on our Board of Directors includes his extensive experience in the dermatology medical device, pharmaceutical industries and his role as Chief Executive Officer of the Company. |
Data sourced from SEC filings. Last updated: 2026-03-05